Relay Therapeutics Inc (RLAY)

Nov 20, 2024

Down -27.93% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 20, 2024

Nov 19, 2024

Down -23.95% in 4 Weeks, Here's Why Relay Therapeutics (RLAY) Looks Ripe for a Turnaround - Yahoo Finance

Nov 19, 2024

Nov 19, 2024

First Turn Management LLC Buys New Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - MarketBeat

Nov 19, 2024

Nov 18, 2024

Layoff Tracker: Adaptimmune Downsizes by 33% in Strategic Realignment - BioSpace

Nov 18, 2024

Nov 17, 2024

Relay Therapeutics (NASDAQ:RLAY) Trading Down 4.8% – Here’s What Happened - Defense World

Nov 17, 2024

Nov 15, 2024

Relay Therapeutics (NASDAQ:RLAY) Stock Price Down 4.8%Time to Sell? - MarketBeat

Nov 15, 2024

Nov 14, 2024

(RLAY) Trading Report - Stock Traders Daily

Nov 14, 2024

Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 - Investing.com India

Nov 14, 2024

Nov 14, 2024

Relay Therapeutics stock hits 52-week low at $5.59 By Investing.com - Investing.com UK

Nov 14, 2024

Nov 14, 2024

Analyzing Valneva (NASDAQ:VALN) and Relay Therapeutics (NASDAQ:RLAY) - Defense World

Nov 14, 2024

Nov 14, 2024

NKGen Biotech (NYSE:NKGN) versus Relay Therapeutics (NASDAQ:RLAY) Financial Contrast - Defense World

Nov 14, 2024

Nov 13, 2024

Relay Therapeutics' SWOT analysis: PI3K inhibitor progress fuels stock potential - Investing.com

Nov 13, 2024

Nov 12, 2024

HC Wainwright Forecasts Strong Price Appreciation for Relay Therapeutics (NASDAQ:RLAY) Stock - Defense World

Nov 12, 2024

Nov 11, 2024

Research Analysts Offer Predictions for RLAY FY2024 Earnings - MarketBeat

Nov 11, 2024

Nov 11, 2024

FY2024 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World

Nov 11, 2024

Nov 09, 2024

Relay Therapeutics (NASDAQ:RLAY) Given New $20.00 Price Target at HC Wainwright - MarketBeat

Nov 09, 2024

Nov 07, 2024

Relay Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024

Nov 07, 2024

RLAYRelay Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 07, 2024

Nov 07, 2024

Relay Therapeutics Reports Q3 2024 Results and Advances - TipRanks

Nov 07, 2024

Nov 06, 2024

Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights - The Manila Times

Nov 06, 2024

Nov 06, 2024

Relay Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 04, 2024

Where are the Opportunities in (RLAY) - Stock Traders Daily

Nov 04, 2024

Oct 31, 2024

Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat

Oct 31, 2024

Oct 31, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts - Investing.com Australia

Oct 31, 2024

Oct 30, 2024

Relay Therapeutics stock hits 52-week low at $5.7 amid market shifts By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024 - The Manila Times

Oct 30, 2024

Oct 30, 2024

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, - EIN News

Oct 30, 2024

Oct 29, 2024

Intrahepatic Cholangiocarcinoma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Key Companies involved by DelveInsight | Xencor, Relay Therapeutics, Kinnate Biopharma, Forma Therapy - Barchart

Oct 29, 2024

Oct 28, 2024

Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses - Yahoo Finance

Oct 28, 2024

Oct 28, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 28, 2024

Oct 25, 2024

Several Relay Therapeutics Insiders Sell Shares Sending Potential Negative Signal - Simply Wall St

Oct 25, 2024

Oct 25, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase - Investing.com Canada

Oct 25, 2024

Oct 24, 2024

Relay Therapeutics' SWOT analysis: oncology innovator's stock faces pivotal phase By Investing.com - Investing.com South Africa

Oct 24, 2024

Oct 16, 2024

Financial Snapshot: Analyzing Relay Therapeutics Inc (RLAY)’s Key Ratio Metrics - The Dwinnex

Oct 16, 2024

Oct 15, 2024

Relay Therapeutics, Inc. (NASDAQ:RLAY) Short Interest Update - MarketBeat

Oct 15, 2024

Oct 14, 2024

How did Relay Therapeutics Inc (RLAY) fare last session? - US Post News

Oct 14, 2024

Oct 14, 2024

Relay Therapeutics (NASDAQ:RLAY) Receives Buy Rating from HC Wainwright - MarketBeat

Oct 14, 2024

Oct 14, 2024

Relay Therapeutics stock holds price target on FDA approval By Investing.com - Investing.com UK

Oct 14, 2024

Oct 14, 2024

Relay Therapeutics Inc (RLAY) receives a Buy rating from Jefferies - Knox Daily

Oct 14, 2024